So, revenue guidance for Lympro is expected on this upcoming call. September 2nd is only 2 weeks away. Should see price appreciation toward that event. Helping that is knowing data and CLIA partner will come within the month of September as well. GC did mention they may add patients to the study to add power, so don't be surprised if data and partner is later in Sept. Just a guess. Being conservative. However, if they want to launch in 2014 it really needs to happen during the month of September.